Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
AIDS Patient Care and Stds|February 19, 2015
A qualitative study of patient motivation to adhere to combination antiretroviral therapy in South AfricaFrancois van Loggerenberg, Debra Gray, Santhanalakshmi Gengiah, et al.AIDS and Behavior|July 10, 2026
Evaluating Motivational Interviewing and Peer Adherence Support as Strategies to Improve Oral PrEP Adherence among HIV-Negative Adults in KwaZulu-Natal, South AfricaSherishka Dhindayal, Sanele Mbeje, Lara Lewis, et al.Journal of the International AIDS Society|April 16, 2026
Impact of Tenofovir Alafenamide Sub-Dermal Implant Insertion Site Scarring on Acceptability and HIV Prevention Preferences: A Prospective Cohort Study in Durban, South AfricaTanuja N Gengiah, Lara Lewis, Ishana Harkoo, et al.European Journal of Clinical Pharmacology|November 24, 2011
The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosisTanuja N Gengiah, Nicholas H G Holford, Julia H Botha, et al.AIDS and Behavior|March 20, 2014
Monitoring microbicide gel use with real-time notification of the container's opening events: results of the CAPRISA Wisebag studyTanuja N Gengiah, Michele Upfold, Anushka Naidoo, et al.AIDS and Behavior|April 4, 2014
Individualised motivational counselling to enhance adherence to antiretroviral therapy is not superior to didactic counselling in South African patients: findings of the CAPRISA 058 randomised controlled trialFrancois van Loggerenberg, Alison D Grant, Kogieleum Naidoo, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 17, 2015
Genital Tenofovir Concentrations Correlate With Protection Against HIV Infection in the CAPRISA 004 Trial: Importance of Adherence for Microbicide EffectivenessAngela D M Kashuba, Tanuja N Gengiah, Lise Werner, et al.Health SA = SA Gesondheid|November 7, 2025
Willingness to switch to injectable cabotegravir among oral PrEP users in Durban, South AfricaTanuja N Gengiah, Vaishnavi Naidoo, Nothile Dlamini, et al.Antiviral Therapy|November 2, 2013
Changes to antiretroviral drug regimens during integrated TB-HIV treatment: results of the SAPiT trialAnushka Naidoo, Kogieleum Naidoo, Nonhlanhla Yende-Zuma, et al.AIDS and Behavior|March 14, 2014
Measuring adherence by visual inspection of returned empty gel applicators in the CAPRISA 004 microbicide trialTanuja N Gengiah, Leila E Mansoor, Michele Upfold, et al.Pageof 4